Nicole Altomare

Dr. Nicole Altomare

Northwestern Medicine, Chicago, Illinois, USA
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 November 2020 in Pathogens
Verified
Journal Article
Open access
PDF file
Erin McDonnellErin McDonnell
Erin McDonnell
Nicole AltomareNicole Altomare
Nicole Altomare
Yesha ParekhYesha Parekh
Yesha Parekh
RGRam C. Gowda
Ram C. Gowda
PPPayal D. Parikh
Payal D. Parikh
MBMartin Blaser
Martin Blaser
Coronavirus 2019 (COVID-19) has been reported to trigger Guillain–Barré syndrome (GBS). While uncommon, recurrent GBS (rGBS) episodes, triggered by antecedent viral infections, have been reported in a small proportion of GBS patients, here we describe a patient with a recurrent case of GBS, occurring secondary to COVID-19 infection. Before this patient’s episode, he had two prior GBS flares, each precipitated by a viral infection followed by complete recovery besides intermittent paresthesias. We also consider the nosology of this illness in the spectrum of rGBS and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), with their differing natural histories, prognosis, and therapeutic approaches. For patients who have a history of inflammatory demyelinating polyradiculopathies who develop COVID-19, we recommend close observation for neurologic symptoms over the next days and weeks.

8 December 2023 in Journal of Surgical Oncology
Verified
Journal Article
Closed access
Nicole AltomareNicole Altomare
Nicole Altomare
MMMary F. Mulcahy
Mary F. Mulcahy

11 May 2021 in Viruses
Verified
Journal Article
Open access
PDF file
Yesha ParekhYesha Parekh
Yesha Parekh
Nicole AltomareNicole Altomare
Nicole Altomare
Erin McDonnellErin McDonnell
Erin McDonnell
MBMartin Blaser
Martin Blaser
PPPayal D. Parikh
Payal D. Parikh
Infection with SARS-CoV-2 leading to COVID-19 induces hyperinflammatory and hypercoagulable states, resulting in arterial and venous thromboembolic events. Deep vein thrombosis (DVT) has been well reported in COVID-19 patients. While most DVTs occur in a lower extremity, involvement of the upper extremity is uncommon. In this report, we describe the first reported patient with an upper extremity DVT recurrence secondary to COVID-19 infection.

9 May 2022 in EMJ Diabetes
Verified
Journal Article
Open access
Nicole AltomareNicole Altomare
Nicole Altomare
DCDavid A Cohen
David A Cohen
Patients with diabetes who are infected with severe acute respiratory syndrome coronavirus 2 experience a worsening of glycaemic control and are at increased risk for severe outcomes. Little is known regarding the impact of COVID-19 vaccinations on glycaemic control. This case report explores a patient with diabetes who experienced an acute worsening of glucose control in the week following the second dose of the Pfizer-BioNTech COVID-19 vaccine.